K. Hance, W. Anderson, S. Devesa, H. Young, and P. Levine, Trends in Inflammatory Breast Carcinoma Incidence and Survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute, JNCI Journal of the National Cancer Institute, vol.97, issue.13, pp.966-75, 2005.
DOI : 10.1093/jnci/dji172

J. Matro, T. Li, M. Cristofanilli, M. Hughes, R. Ottesen et al., Inflammatory Breast Cancer Management in the National Comprehensive Cancer Network: The Disease, Recurrence Pattern, and Outcome, Clinical Breast Cancer, vol.15, issue.1, 2014.
DOI : 10.1016/j.clbc.2014.05.005

D. Van-uden, H. Van-laarhoven, A. Westenberg, J. De-wilt, and C. Blanken-peeters, Inflammatory breast cancer: An overview, Critical Reviews in Oncology/Hematology, vol.93, issue.2, pp.116-142, 2015.
DOI : 10.1016/j.critrevonc.2014.09.003

S. Dawood, N. Ueno, and M. Cristofanilli, The Medical Treatment of Inflammatory Breast Cancer, Seminars in Oncology, vol.35, issue.1, pp.64-71, 2008.
DOI : 10.1053/j.seminoncol.2007.11.012

J. Luo, N. Solimini, and S. Elledge, Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction, Cell, vol.136, issue.5, pp.823-860, 2009.
DOI : 10.1016/j.cell.2009.02.024

I. Weinstein and A. Joe, Mechanisms of Disease: oncogene addiction???a rationale for molecular targeting in cancer therapy, Nature Clinical Practice Oncology, vol.8, issue.8, pp.448-57, 2006.
DOI : 10.1038/ncponc0558

N. Houchens and S. Merajver, Molecular determinants of the inflammatory breast cancer phenotype, Oncology, vol.22, issue.14, pp.1556-61, 1576.

F. Bertucci, P. Finetti, P. Vermeulen, P. Van-dam, L. Dirix et al., Genomic profiling of inflammatory breast cancer: A review, The Breast, vol.23, issue.5, pp.538-583, 2014.
DOI : 10.1016/j.breast.2014.06.008

J. Silva, M. Li, K. Chang, W. Ge, M. Golding et al., Secondgeneration shRNA libraries covering the mouse and human genomes, Nat Genet, vol.37, issue.11, pp.1281-1289, 2005.

P. Paddison, J. Silva, D. Conklin, M. Schlabach, M. Li et al., A resource for large-scale RNA-interference-based screens in mammals, Nature, vol.428, issue.6981, pp.427-458, 2004.
DOI : 10.1038/nature02370

J. Silva, E. Ezhkova, J. Silva, S. Heart, M. Castillo et al., Cyfip1 Is a Putative Invasion Suppressor in Epithelial Cancers, Cell, vol.137, issue.6, pp.1047-61, 2009.
DOI : 10.1016/j.cell.2009.04.013

J. Silva, K. Marran, J. Parker, J. Silva, M. Golding et al., Profiling Essential Genes in Human Mammary Cells by Multiplex RNAi Screening, Science, vol.319, issue.5863, pp.617-637, 2008.
DOI : 10.1126/science.1149185

R. Rodriguez-barrueco, N. Marshall, and J. Silva, Pooled shRNA Screenings: Experimental Approach, Methods Mol Biol, vol.980, pp.353-70, 2013.
DOI : 10.1007/978-1-62703-287-2_21

J. Yu, P. Putcha, A. Califano, and J. Silva, Pooled ShRNA Screenings: Computational Analysis, Methods Mol Biol, vol.980, pp.371-84, 2013.
DOI : 10.1007/978-1-62703-287-2_22

R. Marcotte, K. Brown, F. Suarez, A. Sayad, K. Karamboulas et al., Essential Gene Profiles in Breast, Pancreatic, and Ovarian Cancer Cells, Cancer Discovery, vol.2, issue.2, pp.172-89, 2012.
DOI : 10.1158/2159-8290.CD-11-0224

R. Brough, J. Frankum, D. Sims, A. Mackay, A. Mendes-pereira et al., Functional Viability Profiles of Breast Cancer, Cancer Discovery, vol.1, issue.3, pp.260-73, 2011.
DOI : 10.1158/2159-8290.CD-11-0107

C. Lord, S. Mcdonald, S. Swift, N. Turner, and A. Ashworth, A high-throughput RNA interference screen for DNA repair determinants of PARP inhibitor sensitivity, DNA Repair, vol.7, issue.12, pp.2010-2019, 2008.
DOI : 10.1016/j.dnarep.2008.08.014

Y. Kawaguchi, J. Kovacs, A. Mclaurin, J. Vance, A. Ito et al., The Deacetylase HDAC6 Regulates Aggresome Formation and Cell Viability in Response to Misfolded Protein Stress, Cell, vol.115, issue.6, pp.727-765, 2003.
DOI : 10.1016/S0092-8674(03)00939-5

P. Matthias, M. Yoshida, and S. Khochbin, HDAC6 a new cellular stress surveillance factor, Cell Cycle, vol.7, issue.1, pp.7-10, 2008.
DOI : 10.4161/cc.7.1.5186

C. Boyault, Y. Zhang, S. Fritah, C. Caron, B. Gilquin et al., HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates, Genes & Development, vol.21, issue.17, pp.2172-81, 2007.
DOI : 10.1101/gad.436407
URL : https://hal.archives-ouvertes.fr/inserm-00333430

L. Santo, T. Hideshima, A. Kung, J. Tseng, D. Tamang et al., Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma, Blood, vol.119, issue.11, pp.2579-89, 2012.
DOI : 10.1182/blood-2011-10-387365

D. Sims, A. Mendes-pereira, J. Frankum, D. Burgess, M. Cerone et al., High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing, Genome Biology, vol.12, issue.10, p.104, 2011.
DOI : 10.1073/pnas.0810485105

M. Bassik, R. Lebbink, L. Churchman, N. Ingolia, W. Patena et al., Rapid creation and quantitative monitoring of high coverage shRNA libraries, Nature Methods, vol.6, issue.6, pp.443-448, 2009.
DOI : 10.1073/pnas.0403954101

C. Fellmann, J. Zuber, K. Mcjunkin, K. Chang, C. Malone et al., Functional Identification of Optimized RNAi Triggers Using a Massively Parallel Sensor Assay, Molecular Cell, vol.41, issue.6, pp.733-779, 2011.
DOI : 10.1016/j.molcel.2011.02.008

P. Baldi and A. Long, A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes, Bioinformatics, vol.17, issue.6, pp.509-528, 2001.
DOI : 10.1093/bioinformatics/17.6.509

C. Chang, W. Cheng, C. Chen, W. Shu, M. Tsai et al., Identification of Human Housekeeping Genes and Tissue-Selective Genes by Microarray Meta-Analysis, PLoS ONE, vol.35, issue.7, p.22859, 2011.
DOI : 10.1371/journal.pone.0022859.s013

W. Da-huang, B. Sherman, and R. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nature Protocols, vol.99, issue.1, pp.44-57, 2009.
DOI : 10.1038/nprot.2008.211

A. Subramanian, P. Tamayo, V. Mootha, S. Mukherjee, B. Ebert et al., Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles, Proceedings of the National Academy of Sciences, vol.102, issue.43, pp.15545-50, 2005.
DOI : 10.1073/pnas.0506580102

A. Margolin, I. Nemenman, K. Basso, C. Wiggins, G. Stolovitzky et al., ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context, BMC Bioinformatics, vol.7, issue.Suppl 1, p.7, 2006.
DOI : 10.1186/1471-2105-7-S1-S7

E. Piovan, J. Yu, V. Tosello, D. Herranz, A. Ambesi-impiombato et al., Direct Reversal of Glucocorticoid Resistance by AKT Inhibition in Acute Lymphoblastic Leukemia, Cancer Cell, vol.24, issue.6, pp.766-76, 2013.
DOI : 10.1016/j.ccr.2013.10.022

C. Lefebvre, P. Rajbhandari, M. Alvarez, P. Bandaru, W. Lim et al., A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers, Molecular Systems Biology, vol.3909, p.377, 2010.
DOI : 10.1186/gb-2006-7-7-r55

M. Carro, W. Lim, M. Alvarez, R. Bollo, X. Zhao et al., The transcriptional network for mesenchymal transformation of brain tumours, Nature, vol.61, issue.7279, pp.318-343, 2010.
DOI : 10.1038/nature08712

B. Efron and R. Tibshirani, On testing the significance of sets of genes, The Annals of Applied Statistics, vol.1, issue.1, pp.107-136, 2007.
DOI : 10.1214/07-AOAS101

R. Rodriguez-barrueco, J. Yu, L. Saucedo-cuevas, M. Olivan, D. Llobet-navas et al., breast cancers, Genes & Development, vol.29, issue.15, pp.1631-1679, 2015.
DOI : 10.1101/gad.262642.115
URL : https://hal.archives-ouvertes.fr/inserm-01254136

T. Wang, J. Wei, D. Sabatini, and E. Lander, Genetic Screens in Human Cells Using the CRISPR-Cas9 System, Science, vol.343, issue.6166, pp.80-84, 2014.
DOI : 10.1126/science.1246981

M. Schlabach, J. Luo, N. Solimini, G. Hu, Q. Xu et al., Cancer Proliferation Gene Discovery Through Functional Genomics, Science, vol.319, issue.5863, pp.620-624, 2008.
DOI : 10.1126/science.1149200

C. Scholl, S. Frohling, I. Dunn, A. Schinzel, D. Barbie et al., Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells, Cell, vol.137, issue.5, pp.821-855, 2009.
DOI : 10.1016/j.cell.2009.03.017

R. Neve, K. Chin, J. Fridlyand, J. Yeh, F. Baehner et al., A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes, Cancer Cell, vol.10, issue.6, pp.515-542, 2006.
DOI : 10.1016/j.ccr.2006.10.008

B. Luo, H. Cheung, A. Subramanian, T. Sharifnia, M. Okamoto et al., Highly parallel identification of essential genes in cancer cells, Proceedings of the National Academy of Sciences, vol.105, issue.51, pp.20380-20385, 2008.
DOI : 10.1073/pnas.0810485105

C. Hubbert, A. Guardiola, R. Shao, Y. Kawaguchi, A. Ito et al., HDAC6 is a microtubule-associated deacetylase, Nature, vol.417, issue.6887, pp.455-463, 2002.
DOI : 10.1038/417455a

D. Vreese, R. Verhaeghe, T. Desmet, T. , D. Hooghe et al., Potent and selective HDAC6 inhibitory activity of N-(4-hydroxycarbamoylbenzyl)-1,2,4,9-tetrahydro-3-thia-9-azafluorenes as novel sulfur analogues of Tubastatin A, Chemical Communications, vol.6, issue.36, pp.3775-3782, 2013.
DOI : 10.1039/c3cc41422a

A. Klopp, L. Lacerda, A. Gupta, B. Debeb, T. Solley et al., Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells, PLoS ONE, vol.21, issue.8, p.12180, 2010.
DOI : 10.1371/journal.pone.0012180.s004

M. Alpaugh, J. Tomlinson, Z. Shao, and S. Barsky, A novel human xenograft model of inflammatory breast cancer, Cancer Res, vol.59, issue.20, pp.5079-84, 1999.

Y. Xiao, Y. Ye, K. Yearsley, S. Jones, and S. Barsky, The Lymphovascular Embolus of Inflammatory Breast Cancer Expresses a Stem Cell-Like Phenotype, The American Journal of Pathology, vol.173, issue.2, pp.561-74, 2008.
DOI : 10.2353/ajpath.2008.071214

I. Bekhouche, P. Finetti, A. J. Ferrari, A. Tarpin, C. Charafe-jauffret et al., High-Resolution Comparative Genomic Hybridization of Inflammatory Breast Cancer and Identification of Candidate Genes, PLoS ONE, vol.27, issue.2, p.16950, 2011.
DOI : 10.1371/journal.pone.0016950.s013

K. Basso, A. Margolin, G. Stolovitzky, U. Klein, R. Dalla-favera et al., Reverse engineering of regulatory networks in human B cells, Nature Genetics, vol.14, issue.4, pp.382-90, 2005.
DOI : 10.1101/gad.906601

A. Aytes, A. Mitrofanova, C. Lefebvre, M. Alvarez, M. Castillo-martin et al., Cross-Species Regulatory Network Analysis Identifies a Synergistic Interaction between FOXM1 and CENPF that Drives Prostate Cancer Malignancy, Cancer Cell, vol.25, issue.5, pp.638-51, 2014.
DOI : 10.1016/j.ccr.2014.03.017

C. Lefebvre, G. Rieckhof, and A. Califano, Reverse-engineering human regulatory networks, Wiley Interdisciplinary Reviews: Systems Biology and Medicine, vol.124, issue.4, pp.311-336, 2012.
DOI : 10.1002/wsbm.1159
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128340

F. Bertucci, P. Finetti, J. Rougemont, E. Charafe-jauffret, N. Cervera et al., Gene Expression Profiling Identifies Molecular Subtypes of Inflammatory Breast Cancer, Cancer Research, vol.65, issue.6, pp.2170-2178, 2005.
DOI : 10.1158/0008-5472.CAN-04-4115

C. Perou, T. Sorlie, M. Eisen, M. Van-de-rijn, S. Jeffrey et al., Molecular portraits of human breast tumours, Nature, vol.406, issue.6797, pp.747-52, 2000.
DOI : 10.1038/35021093

J. Yan, Interplay Between HDAC6 and Its Interacting Partners: Essential Roles in the Aggresome-Autophagy Pathway and Neurodegenerative Diseases, DNA and Cell Biology, vol.33, issue.9, pp.567-80, 2014.
DOI : 10.1089/dna.2013.2300

D. Ron and P. Walter, Signal integration in the endoplasmic reticulum unfolded protein response, Nature Reviews Molecular Cell Biology, vol.300, issue.7, pp.519-548, 2007.
DOI : 10.1038/nrm2199

C. Xu, B. Bailly-maitre, and J. Reed, Endoplasmic reticulum stress: cell life and death decisions, Journal of Clinical Investigation, vol.115, issue.10, pp.2656-64, 2005.
DOI : 10.1172/JCI26373

J. Lee, Y. Nagano, J. Taylor, K. Lim, and T. Yao, Disease-causing mutations in Parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy, The Journal of Cell Biology, vol.189, issue.4, pp.671-680, 2010.
DOI : 10.1073/pnas.240347797

F. Hu and F. Liu, Mitochondrial stress: A bridge between mitochondrial dysfunction and metabolic diseases?, Cellular Signalling, vol.23, issue.10, pp.1528-1561, 2011.
DOI : 10.1016/j.cellsig.2011.05.008

I. Shokolenko, N. Venediktova, A. Bochkareva, G. Wilson, and M. Alexeyev, Oxidative stress induces degradation of mitochondrial DNA, Nucleic Acids Research, vol.37, issue.8, pp.2539-2587, 2009.
DOI : 10.1093/nar/gkp100

G. Evan and K. Vousden, Proliferation, cell cycle and apoptosis in cancer, Nature, vol.411, issue.6835, pp.342-350, 2001.
DOI : 10.1038/35077213

N. Danial and S. Korsmeyer, Cell Death, Cell, vol.116, issue.2, pp.205-224, 2004.
DOI : 10.1016/S0092-8674(04)00046-7

S. Chen, Y. Zhang, L. Zhou, Y. Leng, H. Lin et al., A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis, Blood, vol.124, issue.17, pp.2687-97, 2014.
DOI : 10.1182/blood-2014-03-564534

T. Hideshima, P. Richardson, and K. Anderson, Mechanism of Action of Proteasome Inhibitors and Deacetylase Inhibitors and the Biological Basis of Synergy in Multiple Myeloma, Molecular Cancer Therapeutics, vol.10, issue.11, pp.2034-2076, 2011.
DOI : 10.1158/1535-7163.MCT-11-0433

V. Kekatpure, A. Dannenberg, and K. Subbaramaiah, HDAC6 Modulates Hsp90 Chaperone Activity and Regulates Activation of Aryl Hydrocarbon Receptor Signaling, Journal of Biological Chemistry, vol.284, issue.12, pp.7436-7481, 2009.
DOI : 10.1074/jbc.M808999200

D. Qian, S. Kachhap, S. Collis, H. Verheul, M. Carducci et al., Class II Histone Deacetylases Are Associated with VHL-Independent Regulation of Hypoxia-Inducible Factor 1??, Cancer Research, vol.66, issue.17, pp.8814-8835, 2006.
DOI : 10.1158/0008-5472.CAN-05-4598

D. Hurst, A. Mehta, B. Moore, P. Phadke, W. Meehan et al., Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone, Biochemical and Biophysical Research Communications, vol.348, issue.4, pp.1429-1464, 2006.
DOI : 10.1016/j.bbrc.2006.08.005

P. Bali, M. Pranpat, J. Bradner, M. Balasis, W. Fiskus et al., Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90: A NOVEL BASIS FOR ANTILEUKEMIA ACTIVITY OF HISTONE DEACETYLASE INHIBITORS, Journal of Biological Chemistry, vol.280, issue.29, pp.26729-26763, 2005.
DOI : 10.1074/jbc.C500186200

S. Fernandez, F. Robertson, J. Pei, L. Aburto-chumpitaz, Z. Mu et al., Inflammatory breast cancer (IBC): clues for targeted therapies, Breast Cancer Research and Treatment, vol.6, issue.7, pp.23-33, 2013.
DOI : 10.1007/s10549-013-2600-4

G. Tinoco, S. Warsch, S. Gluck, K. Avancha, and A. Montero, Treating Breast Cancer in the 21st Century: Emerging Biological Therapies, Journal of Cancer, vol.4, issue.2, pp.117-149, 2013.
DOI : 10.7150/jca.4925

A. Marcus, J. Zhou, O. Brate, A. Hamel, E. Wong et al., The Synergistic Combination of the Farnesyl Transferase Inhibitor Lonafarnib and Paclitaxel Enhances Tubulin Acetylation and Requires a Functional Tubulin Deacetylase, Cancer Research, vol.65, issue.9, pp.3883-93, 2005.
DOI : 10.1158/0008-5472.CAN-04-3757